ATE259814T1 - Substituierte metallphthalocyaninen, ihre herstellung und verwendung - Google Patents

Substituierte metallphthalocyaninen, ihre herstellung und verwendung

Info

Publication number
ATE259814T1
ATE259814T1 AT00112654T AT00112654T ATE259814T1 AT E259814 T1 ATE259814 T1 AT E259814T1 AT 00112654 T AT00112654 T AT 00112654T AT 00112654 T AT00112654 T AT 00112654T AT E259814 T1 ATE259814 T1 AT E259814T1
Authority
AT
Austria
Prior art keywords
metallphthalocyanines
substituted
production
blood
mycotic
Prior art date
Application number
AT00112654T
Other languages
English (en)
Inventor
Gabrio Roncucci
Lia Fantetti
Filippis Maria Paola De
Donata Dei
Giulio Jori
Original Assignee
Molteni & C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molteni & C filed Critical Molteni & C
Application granted granted Critical
Publication of ATE259814T1 publication Critical patent/ATE259814T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C07C255/51—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings containing at least two cyano groups bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00112654T 2000-06-15 2000-06-15 Substituierte metallphthalocyaninen, ihre herstellung und verwendung ATE259814T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00112654A EP1164135B1 (de) 2000-06-15 2000-06-15 Substituierte Metallphthalocyaninen, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ATE259814T1 true ATE259814T1 (de) 2004-03-15

Family

ID=8168978

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00112654T ATE259814T1 (de) 2000-06-15 2000-06-15 Substituierte metallphthalocyaninen, ihre herstellung und verwendung

Country Status (13)

Country Link
US (2) US7144879B2 (de)
EP (1) EP1164135B1 (de)
JP (1) JP5137282B2 (de)
AT (1) ATE259814T1 (de)
AU (2) AU2001272463B2 (de)
CA (1) CA2412750C (de)
DE (1) DE60008354T2 (de)
DK (1) DK1164135T3 (de)
ES (1) ES2215522T3 (de)
IL (2) IL153447A0 (de)
PT (1) PT1164135E (de)
WO (1) WO2001096343A1 (de)
ZA (1) ZA200300381B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1381611B1 (de) * 2001-03-21 2005-06-22 L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI Metallsubstituierte, nicht zentrosymmetrische phthalocyanin-analoga, deren herstellung und verwendung zur photodynamischen therapie, und als in-vivo-diagnostikum
IL161650A0 (en) 2001-10-29 2004-09-27 Molteni & C Dei Flii Alittisoc Separation of regioisomers of metal phthalocyanines
ES2244694T3 (es) * 2002-04-25 2005-12-16 L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI Composiciones antibacterianas que comprenden analogos de metal ftalocianina.
ITFI20020200A1 (it) 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
ITFI20050092A1 (it) 2005-05-05 2006-11-06 Molteni & C Derivati ftalocianinici, processo per la loro preparazione, composizioni farmaceutiche che li contengono e loro uso
ITFI20050093A1 (it) * 2005-05-05 2006-11-06 Molteni & C Processo per la preparazione di cloruri di derivati ftalocianinici comprendenti almeno un gruppo ammonio quaternario
JP2009500462A (ja) * 2005-06-29 2009-01-08 エル．モルテニ アンド シー．デイ フラテッリ アリッチ ソシエタ’ディ エセルチヅィオ ソシエタ ペル アチオニ 自己滅菌性製品
EP1904060B1 (de) * 2005-06-29 2011-06-01 L. Molteni & C. Dei Fratelli Alitti Societa' Di Esercizio Societa' Per Azioni Verwendung von phthalocyanin-derivaten zur nicht-photodynamischen behandlung von erkrankungen
US8030342B2 (en) 2006-11-08 2011-10-04 Nihon University Dendritic polyamidoamine phthalocyanine derivative
JP4510929B1 (ja) * 2009-04-09 2010-07-28 パナソニック株式会社 テロメラーゼ反応阻害方法およびそれに用いられるテロメラーゼ反応阻害剤
CN102006871B (zh) * 2009-04-09 2013-05-22 松下电器产业株式会社 端粒酶反应的抑制方法
ITFI20110166A1 (it) 2011-08-05 2013-02-06 Molteni & C Nuovi fotosensibilizzanti ad uso terapeutico.
CN102499924B (zh) * 2011-11-23 2013-07-24 中国医学科学院生物医学工程研究所 二乙撑三胺五乙酸或乙二胺四乙酸或胺三乙酸修饰卟啉的用途
CN104003994A (zh) * 2014-06-03 2014-08-27 南京师范大学 一种阳离子酞菁及其制备和应用
CN106554356B (zh) * 2016-10-25 2017-11-10 深圳市声光动力生物医药科技有限公司 1,4‑二取代酞菁锌配合物及其制备方法和在医药上的应用
FI127163B (en) 2016-11-17 2017-12-29 Tty-Säätiö photosensitizer
WO2019036024A1 (en) 2017-08-17 2019-02-21 Bristol-Myers Squibb Company 2- (1,1'-BIPHENYL) -1H-BENZO [D] IMIDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS AGONISTS OF APELIN AND APJ FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
CN108658995B (zh) * 2018-05-29 2020-05-05 南京师范大学 一种二硫联吡啶修饰锌酞菁及其制备方法和应用
KR102357352B1 (ko) * 2020-01-06 2022-01-28 이화여자대학교 산학협력단 화합물, 상기 화합물을 포함하는 조성물, 상기 화합물을 이용하여 박테리아 세균을 비활성화 또는 사멸시키는 방법
CN111072679B (zh) * 2020-01-16 2022-07-01 福州大学 一种非周边季铵基修饰锌酞菁及其制备方法和应用
CN112028901B (zh) * 2020-10-16 2021-06-01 福州大学 十六铵基修饰的酞菁及其制备方法与作为光动力药物的应用
CN113731310B (zh) * 2021-10-15 2024-01-19 西能化工科技(上海)有限公司 超大粒径的中空可膨胀微球及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1351928A1 (ru) * 1986-06-18 1987-11-15 Институт Биологической И Медицинской Химии Амн Ссср Способ получени производных 1,2,3,4-тетрагидрохинолина
JPH07324170A (ja) * 1993-09-14 1995-12-12 Hiroyoshi Shirai フタロシアニン化合物および製造方法、ニトロ置換フタロシアニン化合物、アミノ置換フタロシアニン化合物、フタロシアニン含有重合体および製造方法、触媒、ならびに光記録媒体
IT1294325B1 (it) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici

Also Published As

Publication number Publication date
ZA200300381B (en) 2004-04-15
DK1164135T3 (da) 2004-06-21
US7144879B2 (en) 2006-12-05
US20070066513A1 (en) 2007-03-22
AU7246301A (en) 2001-12-24
WO2001096343A1 (en) 2001-12-20
DE60008354D1 (de) 2004-03-25
CA2412750A1 (en) 2001-12-20
DE60008354T2 (de) 2004-12-09
CA2412750C (en) 2011-03-29
IL153447A0 (en) 2003-07-06
EP1164135A1 (de) 2001-12-19
US20030170178A1 (en) 2003-09-11
JP5137282B2 (ja) 2013-02-06
JP2004503555A (ja) 2004-02-05
PT1164135E (pt) 2004-06-30
US7749991B2 (en) 2010-07-06
EP1164135B1 (de) 2004-02-18
ES2215522T3 (es) 2004-10-16
IL153447A (en) 2009-06-15
AU2001272463B2 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
ATE259814T1 (de) Substituierte metallphthalocyaninen, ihre herstellung und verwendung
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
ATE309194T1 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
MA27769A1 (fr) Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
DE50310516D1 (de) Fredericamycin-derivate
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
DE60324155D1 (de) Indol-3-carbinol metaboliten als chemotherapeutische und chemopräventive wirkstoffen
BRPI0415525A (pt) derivados de imidazola e seu uso como agentes farmacêuticos
IL158032A (en) Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostics
ATE512968T1 (de) 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6- carboxamid und 2,3,4,5-tetrahydropyrrolo(1,2-a)- diazepin-7-carboxamid- derivate, ihre herstellung und therapeutische verwendung
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
TW200504051A (en) Novel acridine derivatives and their use as medicaments
ATE306283T1 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
AU2001292698A1 (en) Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
DE60119514D1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
ATE482705T1 (de) Antibakterielle behandlung von osteoarthritis
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
ATE433957T1 (de) Amphiphilische trisulphonierte porphyrazine zur photodynamischen medizinischen anwendung
DE60143020D1 (de) 9-alkylamino-1-nitroacridin-derivate
ATE338545T1 (de) Polymaleinimid-verbindungen und ihre medizinische verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1164135

Country of ref document: EP